Maven Securities’s Gossamer Bio GOSS Stock Holding History

Maven Securities’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49,889	Closed	-$433K	–	974
2022 Q1	$433K	Buy	+49,889	New	+$481K	0.02%	582

Other funds holding GOSS

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Maven Securities's GOSS Position: Q2 2022 in Review

Maven Securities sold out of Gossamer Bio (GOSS) in Q2 2022, closing a stake of 49,889 shares — an estimated $433K sold.

Maven Securities first reported a position in GOSS in Q1 2022 and held it in 1 quarter. The position peaked at $433K in Q1 2022. 129 funds tracked by Wall St. Rank hold GOSS as of Q2 2022.

Maven Securities reported no remaining Gossamer Bio position as of Q2 2022 after selling out during the quarter.
Maven Securities sold 49,889 Gossamer Bio shares in Q2 2022, an estimated $433K.
Maven Securities first reported a position in Gossamer Bio in Q1 2022 and held it in 1 quarter.
Maven Securities's Gossamer Bio position peaked at $433K in Q1 2022.
129 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2022.

Based on Maven Securities's 13F filing for Q2 2022, filed 15 Aug 2022.